Martin Plambech is the CEO of Biosyntia, which develops novel fermentation processes. Prior to Biosyntia, he was responsible for business development within Animal Health & Nutrition, Novozymes. He has also worked for Boston Consulting Group in Europe & Australia and been a First Lieutenant in the Danish Army. He holds a M.Sc. in Finance & Strategic Management from Copenhagen Business School.